Controlled human infection models to accelerate vaccine development

RKM Choy, AL Bourgeois… - Clinical Microbiology …, 2022 - Am Soc Microbiol
The timelines for developing vaccines against infectious diseases are lengthy, and often
vaccines that reach the stage of large phase 3 field trials fail to provide the desired level of …

Sporozoite immunization: innovative translational science to support the fight against malaria

TL Richie, LWP Church, T Murshedkar… - Expert review of …, 2023 - Taylor & Francis
Introduction Malaria, a devastating febrile illness caused by protozoan parasites, sickened
247,000,000 people in 2021 and killed 619,000, mostly children and pregnant women in …

Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a …

MS Sissoko, SA Healy, A Katile, I Zaidi, Z Hu… - The Lancet Infectious …, 2022 - thelancet.com
Background WHO recently approved a partially effective vaccine that reduces clinical
malaria in children, but increased vaccine activity is required to pursue malaria elimination …

[HTML][HTML] Safety, immunogenicity, and protective efficacy against controlled human malaria infection of Plasmodium falciparum sporozoite vaccine in Tanzanian adults

SA Jongo, SA Shekalaghe, LWP Church… - The American journal …, 2018 - ncbi.nlm.nih.gov
We are using controlled human malaria infection (CHMI) by direct venous inoculation (DVI)
of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ)(PfSPZ …

[HTML][HTML] Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infections

A Barry, J Bradley, W Stone, MW Guelbeogo… - Nature …, 2021 - nature.com
Plasmodium falciparum gametocyte kinetics and infectivity may differ between chronic and
incident infections. In the current study, we assess parasite kinetics and infectivity to …

[HTML][HTML] A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection

B Mordmüller, Z Sulyok, M Sulyok, Z Molnar… - npj Vaccines, 2022 - nature.com
Immunization with radiation-attenuated Plasmodium falciparum (Pf) sporozoites (SPZ) in
PfSPZ Vaccine, has provided better vaccine efficacy (VE) against controlled human malaria …

[HTML][HTML] Immunogenicity and protective efficacy of radiation-attenuated and chemo-attenuated PfSPZ vaccines in Equatoguinean adults

SA Jongo, V Urbano, LWP Church, A Olotu… - The American journal …, 2021 - ncbi.nlm.nih.gov
Plasmodium falciparum sporozoite (PfSPZ) Vaccine (radiation-attenuated, aseptic, purified,
cryopreserved PfSPZ) and PfSPZ-CVac (infectious, aseptic, purified, cryopreserved PfSPZ …

[HTML][HTML] Safety and differential antibody and T-cell responses to the Plasmodium falciparum sporozoite malaria vaccine, PfSPZ vaccine, by age in Tanzanian adults …

SA Jongo, LWP Church, AT Mtoro… - The American journal …, 2019 - ncbi.nlm.nih.gov
In 2016, there were more cases and deaths caused by malaria globally than in 2015. An
effective vaccine would be an ideal additional tool for reducing malaria's impact. Sanaria® …

Controlled human malaria infection of healthy adults with lifelong malaria exposure to assess safety, immunogenicity, and efficacy of the asexual blood stage malaria …

JC Dejon-Agobe, U Ateba-Ngoa… - Clinical Infectious …, 2019 - academic.oup.com
Background GMZ2 is a recombinant malaria vaccine inducing immune responses against
Plasmodium falciparum (Pf) merozoite surface protein-3 and glutamate-rich protein. We …

[HTML][HTML] Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity

SE de Jong, V van Unen, MD Manurung, KA Stam… - Nature …, 2021 - nature.com
Controlled human infections provide opportunities to study the interaction between the
immune system and malaria parasites, which is essential for vaccine development. Here, we …